自引率: 3.2%
被引量: 31739
通过率: 暂无数据
审稿周期: 2.35
版面费用: 暂无数据
国人发稿量: 109
投稿须知/期刊简介:
The European Journal of Pharmacology publishes full-length papers, short communications and rapid communications on the mechanisms of action of chemical substances affecting biological systems. The journal also considers short reviews (not exceeding 12 pages in print) intended to debate recent advances in rapidly developing fields that are within its scope.Full-length papers and short communications are grouped under the following headings: Behavioral pharmacology, Neuropharmacology and analgesia, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, and Molecular and cellular pharmacology. Manuscripts submitted to the journal are accepted on the understanding that: (1) they are subject to editorial review, (2) they have not been and will not be published in whole or in part in any other journal, and (3) the recommendations from the declaration of Helsinki and the internationally accepted principles in the use of experimental animals have been adhered to.
期刊描述简介:
The European Journal of Pharmacology publishes full-length papers, short communications and rapid communications on the mechanisms of action of chemical substances affecting biological systems. The journal also considers short reviews (not exceeding 12 pages in print) intended to debate recent advances in rapidly developing fields that are within its scope.Full-length papers and short communications are grouped under the following headings: Behavioral pharmacology, Neuropharmacology and analgesia, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, and Molecular and cellular pharmacology. Manuscripts submitted to the journal are accepted on the understanding that: (1) they are subject to editorial review, (2) they have not been and will not be published in whole or in part in any other journal, and (3) the recommendations from the declaration of Helsinki and the internationally accepted principles in the use of experimental animals have been adhered to.
-
Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation.
被引量:- 发表:1970
-
Autophagic inhibitor ROC-325 ameliorates glomerulosclerosis and podocyte injury via inhibiting autophagic flux in experimental FSGS mice.
被引量:- 发表:1970
-
Borneol promotes berberine-induced cardioprotection in a rat model of myocardial ischemia/reperfusion injury via inhibiting P-glycoprotein expression.
被引量:- 发表:1970
-
Harringtonine metabolites: 5'-de-O-methylharringtonine and cephalotaxine, targeting spike protein and TMPRSS2 to double block membrane fusion of SARS-CoV-2 and its variants.
被引量:- 发表:1970
-
Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation.
被引量:- 发表:1970